Currently submitted to: JMIR Research Protocols
Date Submitted: Aug 17, 2026
Open Peer Review Period: Aug 18, 2026 - Oct 13, 2026
(currently open for review)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Ashwagandha Supplementation in Healthy Students: Protocol for the Single-Center Pilot Study SUPplementation and Perceived RESponse to Stress (SUPPRESS)
ABSTRACT
Background:
Academic stress is a major contributor to impaired mental well-being and academic performance among university students. Ashwagandha (Withania somnifera), an Ayurvedic medicinal plant with adaptogenic properties, has been investigated as a potential intervention for stress-related outcomes. However, evidence in otherwise healthy university students remains limited.
Objective:
This study aims to evaluate the effects of an 8-week supplementation regimen with an ashwagandha-containing supplement on perceived stress and related outcomes in healthy university students during the final eight weeks of the academic semester, a period typically characterized by increased academic demands preceding final examinations.
Methods:
This single-center, prospective pilot study employs a single-arm pre–post design and will enroll 35 healthy students from Trier University of Applied Sciences. Participants will receive an ashwagandha-containing multi-ingredient food supplement providing 300 mg/day of standardized Withania somnifera root extract for 8 weeks. The primary outcome is the change in perceived stress from baseline to the end of the 8-week intervention, assessed using the 10-item Perceived Stress Scale (PSS-10). Secondary outcomes include stress and coping assessed using the Stress and Coping Inventory, salivary and urinary cortisol concentrations, urinary epinephrine and norepinephrine concentrations, and nutritional status. Adherence to the supplementation regimen, participant acceptability, and study retention will additionally be assessed. Safety will be evaluated based on participant-reported adverse events. Baseline characteristics, adherence, acceptability, retention, and safety data will be summarized descriptively. Within-participant changes from baseline to the end of the intervention will be analyzed using the Wilcoxon signed-rank test. Ethical approval was obtained on May 20, 2026.
Results:
Participant enrollment commenced on June 1, 2026. A total of 36 participants were enrolled. Data collection is expected to be completed by August 31, 2026, followed by data analysis. Descriptive study results are expected to be available in October 2026.
Conclusions:
This pilot study will provide preliminary estimates of within-participant changes in perceived stress and related psychometric and biochemical stress markers in healthy university students. The findings will provide a basis for refining the study design and informing sample size calculations for a subsequent adequately powered randomized controlled trial.Trial Clinical Trial: German Clinical Trials Register (DRKS), DRKS00040433. Prospectively registered on 22 May 2026.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.